54th Annual Congress on Neuroscience and Stroke

Welcome message:

We’re grateful to welcome you to the “54^th Annual Congress on Neuroscience and Stroke”, which is held on December 04-05, 2023 in Dubai, UAE. Stroke Congress 2023 is an ideal platform to discuss, learn and inform current discoveries and new ideas and will create huge participation from eminent researchers, scientists, Doctors, educators, students, policymakers, and members of associations to network from all over the world with each other and disseminate new trends. Special breakout sessions will further highlight concerned areas on Neuroscience and Neurological disorders and will make way for future research directions. We hope this conference will explore different avenues in these fields and will help you all to gain innovative ideas for further research.

About Conference:

Stroke Congress 2023 is an annual meeting of neurological and stroke specialists and other allied professionals to deliberate innovations with respect to treatment, diagnosis, and rehabilitation for neurological disorders.

Stroke Congress 2023 will feature the latest and arising topics in stroke care, for stroke professionals, neurologists, researchers, and policymakers. The scientific program has been increased to have greater interaction, discussion, and learning that will emphasize basic, clinical, and translational sciences as they evolve toward a better understanding of the pathophysiology of neurological disorders and stroke with the goal of developing more effective therapies.

Stroke Congress 2023 also provides the opportunity to make network with colleagues in the stroke field from around the world with wide-ranging expertise and experience as scientists.

We will look forward to your active engagement and to greeting you in Dubai!

Why attend?

Stroke Congress 2023 this conference offers everyone the to develop their professional skill in the field of neuroscience and strokes also you get a chance to get more knowledge on the latest technologies like Traumatic Brain Injury and Neurosurgery, Clinical Psychology, and Sleep Disorders, Peripheral Nervous System, Spine and Spinal Disorders, Neurotrauma and Neurosurgical Critical Care and you can build new relationships and get a chance to meet new people who are essential for the growth of both personal and make you a better neuroscience practitioner.

This is a great chance to explore your knowledge of Neuroscience. Stroke Congress 2023 Conferences will appraise the world with recent advances in Traumatic Brain Injury and Neurosurgery and implant new ideas about a healthy brain. This conference includes live events Keynote Sessions, Professional talks, Speaker Sessions, and Bill Donations, Video Donations. Attendees will get a better connection with business delegates, academics, and experts in stroke congress 2023 throughout the globe, also there is a chance to build your knowledge of Neurological Disorders and Strokes to make more comfortable and relaxed people also use Neurologists. By attending this conference you can get the best knowledge in neuroscience. This Conferences, discourses, and Workshops give a faithful forum for the enhancement, accomplishment, and exchange of useful data about Neurological Disorders and Strokes.

Target audience:

• Neuroscience  collage Directors

• Principal Neurologist’s

• Neurologists

• CEO of Hospitals

• Researchers in the neurological  field

• Neurological Disorder and Stroke Researchers, Faculty and Students.

• professional’s doctors in the  field of neuroscience can proceed with this conference

• Neurological laboratory heads & researchers

• The audience is comprised of all individuals and groups interested in connecting with or learning more about scholars, in addition to businesses.

Benefits:

• As we all know, education knows no bounds, and pursuing a career as a neurologist or continuing one's study in the field of neurology can greatly enhance one's performance and abilities.

• In the case of neurological professionals, they can also learn about the latest technology that has developed in their field, and they can also build new connections and gain new contacts in their field.

• People in the neurological field can also organize many conferences for neurologists so they can share their latest research and studies regarding oral care with them.

• As anyone knows, many oral health cases arise every day, and how to tackle new challenges to provide a solution for this problem, neuroscience experts must be updated in their niche. For this, attending a neuroscience conference is the best opportunity. 

Market analysis:

Global Overview of Stroke Management

The size of the global stroke management market is expected to increase from USD 33.58 billion in 2021 to USD 55.37 billion by 2028, with a CAGR of 7.6% between 2022 and 2028. The main factors driving the market demand during the predicted period were an increase in product development and rising demand for early diagnosis.

A stroke happens when the blood supply to the brain is reduced or cut off entirely, divesting the brain tissue of oxygen and nutrients. For example, computed tomography (CT SCAN), computed tomography angiography (CTA), magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), transcranial Doppler ultrasonography, and others are among the diagnostic tools used to identify stroke and its possible early symptoms.

The demand for stroke diagnostics has increased in developing nations because of the rising universality of stroke, cardiovascular illness, and neurological disorders. The rise in population and the universality of chronic disorders including diabetes, hypertension, and hyperlipidemia, as well as technological developments in stroke detection and treatment, are driving the growth of the stroke management market. However, the market expansion is being hampered by the lengthy drug acceptance process and the high cost of the procedures used in stroke treatment and diagnostics. However, strict rules can stop the market from expanding.

Impact Stroke Management Market of COVID-19 on the Pandemic :

As a result of the COVID-19 pandemic, the demand for stroke-management medications which will include Alteplase, Clopidogrel, and Atorvastatin surged. This is because the prevalence of stroke raise as a result of the spread of SARS-CoV-2. Due to this, pharmaceutical companies received a large number of orders, which increased their production. The product profit of different drug component manufacturers increased as a result. As a result, during the early stages of the pandemic, there was a raise in the purchase of drug components, which fueled the expansion of the worldwide stroke management industries.

Chronic Diseases Catalyzes and Global Stroke Management Market

One of the elements affecting the expansion of the market is technological innovation. The market for stroke management has significant potential due to the growing use of the MicroTransponder Vivistim Paired VNS System (Vivistim System), which is the first drug-free treatment for all strokes to receive FDA approval. Additionally, growing public knowledge of stroke causes a sharp increase in the disease's diagnosis rates, which in turn drives up the demand for medications that target the condition. Recombinant tissue plasmogen activators, which are currently recommended as first-line therapy, were found to be the most successful treatment for ischemic stroke.

Because blood pressure of more than 140/90mmHg can harm the blood arteries supplying the brain with oxygen-rich blood, hypertension is the main risk factor for stroke. Additionally, hyperglycemia is a significant risk factor for stroke. People with diabetes have twice as high a risk of having a stroke and may also experience an early beginning of the stroke, according to the American Stroke Association. According to the same data, an adult with diabetes is hospitalized or mediated in the US for a stroke every two minutes. As a result, there is a steady rise in the need for stroke drugs, which is expected to continue in the years to come.

Geographical Overview:

Due to the increasing number of stroke occurrences in the world, North America is anticipated to hold the greatest market share globally. Stroke caused 7% of all fatalities in Canada, in 2000. Demographic trends, greater government funding for R&D in both public and commercial institutions, and which will improve public knowledge of the symptoms and prevention of stroke are all factors driving the market's expansion. Due to rising demand for home and healthcare for stroke management, strategic moves by industry participants, and minimally invasive surgery, Asia-Pacific is also anticipated to have the second-largest market share. Johnson & Johnson's PULSERIDER is used to find the aneurysms in all stroke victims.

Stroke Overview in Europe:

438,000 deaths is caused by stroke in Europe in 2017, accounting for 8% of all fatalities. Additionally, stroke has a detrimental impact on many survivors' lives by impairing a variety of functions, making it more difficult for survivors to carry out daily tasks. 3,4 Stroke accounts for 8% of the Euro 798 billion cost of brain illnesses, making it one of the main causes of disability and increased use of health and social care resources.

Stroke overview by type:

The industry is divided into hemorrhagic, ischemic, transient ischemic attack, and other types based on that. By 2032, it is anticipated that the market share from the transient ischemic attack (TIA) sector would exceed USD 1.5 billion. The increasing mortality rate due to the disease, which is encouraging the usage of stroke management devices, is driving the segment outlook. The growing preference for catheter-based devices for interventional procedures to remove thrombi is also anticipated to fuel growth in market data.

Overview by Product:

Aneurysm rates raising will drive demand for treatment devices. The market is divided into therapeutic devices and diagnostic devices based on different kinds of products. By 2032, it is anticipated that the therapeutic devices segment will reach USD 11.5 billion approx. The rising number of aneurysm patients is predicted to be the main driver of segmental expansion. According to the Brain Aneurysm Foundation, 3-5% of all new cases of stroke are caused by burst brain aneurysms. To that aim, the segment prognosis is also anticipated to be outlined by the increasing utilization of therapeutic equipment like surgical clipping.

• Diagnostic Devices

• Magnetic Resonance Imaging (MRI)

• Computed Tomography Scan (CT scan)

• Electrocardiography

• Carotid Ultrasound

• Cerebral Angiography

• Others

• Therapeutic Devices

• Stent retriever

• Surgical clips

• Embolic coils

• Flow diverters

• Aspiration catheters

• Others

• The leading market players in the Global Stroke Management Market are

• Abbott Laboratories,

• B Braun Melsungen AG,

• Boston Scientific Corporation,

• Bristol Myers Squibb Co.,

• Cardinal Health Inc.,

• General Electric Company,

• GlaxoSmithKline Plc,

• Medtronic Plc,

• Merck and Co. Inc.,

• Siemens A